Centessa Pharmaceuticals PLC ADR (CNTA) Insider Trading
- $3,235,137.92
- $1,589,276.62
- March 25, 2024
- Antoine Yver
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 25, 2024 | Insider | 51,160 | $11.88 | Sell | $607,780.80 | |
Feb. 1, 2024 | SVP | 4,267 | $8.10 | Sell | $34,562.70 | |
Sept. 20, 2023 | SVP | 37,484 | $6.29 | Sell | $235,774.36 | |
June 1, 2023 | EVP | 6,500 | $4.45 | Sell | $28,925.00 | |
May 24, 2023 | Insider | 8,000 | $4.48 | Sell | $35,840.00 | |
May 1, 2023 | EVP | 6,800 | $4.42 | Sell | $30,056.00 | |
Jan. 4, 2023 | EVP | 6,970 | $3.18 | Sell | $22,164.60 | |
Dec. 1, 2022 | EVP | 9,400 | $3.91 | Sell | $36,754.00 | |
Nov. 1, 2022 | EVP | 9,700 | $4.03 | Sell | $39,091.00 | |
Oct. 3, 2022 | General Counsel | 4,563 | $3.95 | Sell | $18,023.85 | |
Oct. 3, 2022 | CTO | 2,455 | $3.95 | Sell | $9,697.25 | |
Oct. 3, 2022 | CFO | 4,901 | $3.95 | Sell | $19,358.95 | |
Oct. 3, 2022 | Insider | 4,167 | $3.95 | Sell | $16,459.65 | |
Oct. 3, 2022 | EVP | 12,524 | $3.92 | Sell | $49,094.08 | |
Sept. 30, 2022 | CTO | 2,003 | $4.07 | Sell | $8,152.21 | |
Sept. 30, 2022 | EVP | 2,468 | $4.07 | Sell | $10,044.76 | |
Sept. 30, 2022 | Insider | 3,401 | $4.07 | Sell | $13,842.07 | |
Sept. 30, 2022 | CFO | 4,000 | $4.07 | Sell | $16,280.00 | |
Sept. 30, 2022 | General Counsel | 3,725 | $4.07 | Sell | $15,160.75 | |
Aug. 1, 2022 | EVP | 10,423 | $4.45 | Sell | $46,382.35 | |
July 18, 2022 | EVP | 20,000 | $4.87 | Sell | $97,400.00 | |
July 1, 2022 | EVP | 9,100 | $5.03 | Sell | $45,773.00 | |
June 24, 2022 | CEO | 10,000 | $4.63 | Buy | $46,300.00 | |
June 17, 2022 | EVP | 9,200 | $4.68 | Sell | $43,056.00 | |
May 17, 2022 | EVP | 20,222 | $5.42 | Sell | $109,603.24 | |
Feb. 2, 2022 | CEO | 5,000 | $9.74 | Buy | $48,700.00 | |
Jan. 28, 2022 | Insider | 27,500 | $9.05 | Buy | $248,875.00 | |
Dec. 2, 2021 | Major Shareholder | 34,326 | $12.82 | Buy | $440,059.32 | |
Dec. 1, 2021 | Director | 60,304 | $12.62 | Buy | $761,036.48 | |
Nov. 30, 2021 | Major Shareholder | 36,847 | $11.62 | Buy | $428,162.14 | |
Nov. 29, 2021 | Director | 56,706 | $11.70 | Buy | $663,460.20 | |
Nov. 26, 2021 | Director | 11,817 | $11.34 | Buy | $134,004.78 | |
Nov. 18, 2021 | Director | 10,000 | $11.98 | Buy | $119,800.00 | |
Nov. 16, 2021 | CEO | 23,000 | $12.28 | Buy | $282,440.00 | |
Nov. 16, 2021 | Insider | 5,000 | $12.46 | Buy | $62,300.00 |
Insiders are both buying and selling Centessa Pharmaceuticals PLC ADR stock.
The insider traders at Centessa Pharmaceuticals PLC ADR are: Antoine Yver, Saurabh Saha, Rubertis Francesco De, Harris Rotman, Iqbal J Hussain, Medicxi Ventures Management (J, Tia L Bush, David M Chao, Gregory M Weinhoff, Thomas Templeman, David J Grainger, Aaron Kantoff, and Karen M Anderson
The most active insider trader at Centessa Pharmaceuticals PLC ADR is Antoine Yver with 12 trades.
Karen M Anderson has sold the most Centessa Pharmaceuticals PLC ADR stock with a total value of $1,215,561.60.
Rubertis Francesco De has bought the most Centessa Pharmaceuticals PLC ADR stock with a total value of $2,319,537.94.
The most recent insider trade for Centessa Pharmaceuticals PLC ADR was on March 25, 2024.
The single biggest insider buy for Centessa Pharmaceuticals PLC ADR was from Rubertis Francesco De with a total value of $761,036.48 on Dec. 1, 2021.
The single biggest insider sell for Centessa Pharmaceuticals PLC ADR was from Karen M Anderson with a total value of $607,780.80 on March 25, 2024.